The chemical class known as 17β-HSD3 inhibitors constitutes a distinct group of compounds that have been intricately designed to exert a precise modulatory influence on the enzymatic activity of 17β-Hydroxysteroid Dehydrogenase 3 (17β-HSD3). This enzyme holds a pivotal role in steroid hormone metabolism, orchestrating the conversion of androstenedione to testosterone, a pivotal step in the intricate cascade of androgen biosynthesis. The inhibitors within this class emerge as strategic tools meticulously devised to establish a sophisticated interaction with the active site or other strategically significant regions of the 17β-HSD3 enzyme. In doing so, they intrinsically disrupt the finely choreographed enzymatic function, thereby subtly but effectively influencing the delicate balance of steroid hormone synthesis.
The development of these inhibitors unfolds as an elaborate process that often merges scientific ingenuity with computational prowess. It hinges on the identification of potential binding sites within the intricate three-dimensional architecture of the enzyme. These binding sites, analogous to molecular alcoves, serve as the crux of interaction where the inhibitors elegantly nestle, obstructing the customary substrate-binding trajectory and ensuing biochemical transformation. As the inhibitors occupy these pockets, they form an intricate lock-and-key arrangement, impeding the catalytic machinery of 17β-HSD3 with precision. Invariably, the selectivity and potency of these inhibitors are of paramount importance, aimed at selectively manipulating 17β-HSD3 while circumventing any off-target effects that could inadvertently impact other steroidogenic enzymes.The pursuit of 17β-HSD3 inhibitors burgeons from a fundamental curiosity about the inner workings of steroid hormone pathways, driven by a desire to decode the complex interplay of hormones in various physiological phenomena. These inhibitors stand as sentinel entities, enabling researchers to unveil intricate details of hormone metabolism without straying into the realm of potential applications. They remain at the forefront of elucidating the nuanced symphony of steroidogenesis, each interaction and structural feature contributing to our evolving understanding of hormonal intricacies.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trilostane | 13647-35-3 | sc-208469 sc-208469A | 10 mg 100 mg | $224.00 $1193.00 | 2 | |
Originally developed as an inhibitor of 3β-HSD, trilostane also affects 17β-HSD3 and is used in veterinary research for Cushing's syndrome in dogs. | ||||||
Aminoglutethimide | 125-84-8 | sc-207280 sc-207280A sc-207280B sc-207280C | 1 g 5 g 25 g 100 g | $41.00 $143.00 $530.00 $2020.00 | 2 | |
Although initially developed as an aromatase inhibitor, aminoglutethimide has been known to inhibit 17β-HSD3 as well. | ||||||
Abiraterone | 154229-19-3 | sc-460288 | 10 mg | $276.00 | ||
Used in the research of advanced prostate cancer, abiraterone inhibits multiple enzymes, including 17β-HSD3, to decrease androgen synthesis. | ||||||
Fadrozole hydrochloride | 102676-31-3 | sc-252819 sc-252819A sc-252819B | 10 mg 50 mg 500 mg | $138.00 $530.00 $4080.00 | ||
Another aromatase inhibitor that has also been investigated for its potential to inhibit 17β-HSD3. | ||||||
Liarozole hydrochloride | 145858-50-0 | sc-204055 sc-204055A | 10 mg 50 mg | $159.00 $500.00 | 1 | |
An experimental compound that inhibits both aromatase and 17β-HSD3 enzymes. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $85.00 $144.00 | 5 | |
Primarily known as an aromatase inhibitor, letrozole has been investigated for its effect on 17β-HSD3 as well. | ||||||
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $131.00 $403.00 | ||
Another aromatase inhibitor that might have an impact on 17β-HSD3 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A natural compound found in grapes and other plants, resveratrol has shown potential as an inhibitor of 17β-HSD3. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Derived from turmeric, curcumin has been explored for its potential to inhibit 17β-HSD3 and modulate hormone levels. | ||||||